Your browser doesn't support javascript.
loading
The Burden of Chagas Disease in the Contemporary World: The RAISE Study.
Ribeiro, Antonio Luiz Pinho; Machado, Ísis; Cousin, Ewerton; Perel, Pablo; Demacq, Caroline; Geissbühler, Yvonne; de Souza, Aline; Liprandi, Alvaro Sosa; Nascimento, Bruno R; França, Elisabeth F; Martins-Melo, Francisco Rogerlândio; Roth, Gregory A; Molina, Israel; Noronha, Kenya; Ishitani, Lenice; Carneiro, Mariângela; Quijano, Monica; Andrade, Monica V; Naghavi, Mohsen; Mosser, Jonathan F; Piñeiro, Daniel J.
Affiliation
  • Ribeiro ALP; Hospital das Clínicas da Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 110 -Santa Efigênia, Belo Horizonte -MG, 30130-100, BR.
  • Machado Í; Department of Family Medicine, Mental and Collective Health, Universidade Federal de Ouro Preto, Ouro Preto, Brazil.
  • Cousin E; Institute for Health Metrics and Evaluation (IHME), University of Washington, Seattle, United States of America.
  • Perel P; World Heart Federation, Geneva, Switzerland.
  • Demacq C; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Geissbühler Y; Global Health, Novartis Pharma AG, Basel, Switzerland.
  • de Souza A; Global Health, Novartis Pharma AG, Basel, Switzerland.
  • Liprandi AS; Department of Economics, Faculty of Economic Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Nascimento BR; Cardiology Department, Sanatoria Guemes, Buenos Aires, Argentina.
  • França EF; Hospital das Clínicas da Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 110 -Santa Efigênia, Belo Horizonte -MG, 30130-100, BR.
  • Martins-Melo FR; Postgraduate Program in Public Health, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Roth GA; Instituto Federal de Educação, Ciência e Tecnologia do Ceará - Campus Fortaleza, Fortaleza, Brazil.
  • Molina I; Institute for Health Metrics and Evaluation (IHME), University of Washington, Seattle, United States of America.
  • Noronha K; Department of Medicine, University of Washington, Seattle, United States of America.
  • Ishitani L; International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Carneiro M; Department of Economics, Faculty of Economic Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Quijano M; Epidemiological Surveillance Division, Belo Horizonte Municipal Health Department Belo Horizonte, Brazil.
  • Andrade MV; Department of Parasitology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Naghavi M; Global Health, Novartis Pharma AG, Basel, Switzerland.
  • Mosser JF; Department of Economics, Faculty of Economic Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Piñeiro DJ; Institute for Health Metrics and Evaluation (IHME), University of Washington, Seattle, United States of America.
Glob Heart ; 19(1): 2, 2024.
Article in En | MEDLINE | ID: mdl-38222097
ABSTRACT
Chagas disease (ChD), a Neglected Tropical Disease, has witnessed a transformative epidemiological landscape characterized by a trend of reduction in prevalence, shifting modes of transmission, urbanization, and globalization. Historically a vector-borne disease in rural areas of Latin America, effective control measures have reduced the incidence in many countries, leading to a demographic shift where most affected individuals are now adults. However, challenges persist in regions like the Gran Chaco, and emerging oral transmission in the Amazon basin adds complexity. Urbanization and migration from rural to urban areas and to non-endemic countries, especially in Europe and the US, have redefined the disease's reach. These changing patterns contribute to uncertainties in estimating ChD prevalence, exacerbated by the lack of recent data, scarcity of surveys, and reliance on outdated models. Besides, ChD's lifelong natural history, marked by acute and chronic phases, introduces complexities in diagnosis, particularly in non-endemic regions where healthcare provider awareness is low. The temporal dissociation of infection and clinical manifestations, coupled with underreporting, has rendered ChD invisible in health statistics. Deaths attributed to ChD cardiomyopathy often go unrecognized, camouflaged under alternative causes. Understanding these challenges, the RAISE project aims to reassess the burden of ChD and ChD cardiomyopathy. The project is a collaborative effort of the World Heart Federation, Novartis Global Health, the University of Washington's Institute for Health Metrics and Evaluation, and a team of specialists coordinated by Brazil's Federal University of Minas Gerais. Employing a multidimensional strategy, the project seeks to refine estimates of ChD-related deaths, conduct systematic reviews on seroprevalence and prevalence of clinical forms, enhance existing modeling frameworks, and calculate the global economic burden, considering healthcare expenditures and service access. The RAISE project aspires to bridge knowledge gaps, raise awareness, and inform evidence-based health policies and research initiatives, positioning ChD prominently on the global health agenda.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chagas Cardiomyopathy / Chagas Disease Type of study: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Glob Heart Year: 2024 Type: Article Affiliation country: Brazil

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chagas Cardiomyopathy / Chagas Disease Type of study: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Glob Heart Year: 2024 Type: Article Affiliation country: Brazil